Cargando…
Botulinum Neurotoxins and Botulism: A Novel Therapeutic Approach
Specific treatment is not available for human botulism. Current remedial mainstay is the passive administration of polyclonal antibody to botulinum neurotoxin (BoNT) derived from heterologous species (immunized animal or mouse hybridoma) together with supportive and symptomatic management. The antib...
Autores principales: | Thanongsaksrikul, Jeeraphong, Chaicumpa, Wanpen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202833/ https://www.ncbi.nlm.nih.gov/pubmed/22069720 http://dx.doi.org/10.3390/toxins3050469 |
Ejemplares similares
-
Editorial: New insights on botulism, botulinum neurotoxins, and botulinum toxin-producing clostridia
por: Anniballi, Fabrizio, et al.
Publicado: (2022) -
Ophiophagus hannah Venom: Proteome, Components Bound by Naja kaouthia Antivenin and Neutralization by N. kaouthia Neurotoxin-Specific Human ScFv
por: Danpaiboon, Witchuda, et al.
Publicado: (2014) -
Humanized-Single Domain Antibodies (VH/V(H)H) that Bound Specifically to Naja kaouthia Phospholipase A2 and Neutralized the Enzymatic Activity
por: Chavanayarn, Charnwit, et al.
Publicado: (2012) -
Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs
por: Barker, Douglas, et al.
Publicado: (2019) -
Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate Immunity
por: Jittavisutthikul, Surasak, et al.
Publicado: (2016)